Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs Kongo

By GLP-1 ScorecardUpdated

Our take

For a first order, we would compare Kongo’s one-month option before prepaying. CoreAge is worth a written quote if dose pricing matters, but settle its conflicting billing and refund terms first.

CoreAge Rx: settle the charge and exit terms

Ask for a written quote before ordering. The CoreAge Rx review explains where the advertised prices and refund terms conflict, so you know which charges to confirm.

More on CoreAge Rx

In October 2026, CoreAge Rx’s product pages advertised semaglutide from $79 and tirzepatide from $129 a month. Navigation still promoted semaglutide from $99, and a separate campaign tied starting prices to twelve months paid in full. That annual condition does not establish the product-page offers’ terms. Confirm your selected bill and usable supply instead of comparing headline prices.

CoreAge’s FAQ said no automatic rebills and a full refund after clinical rejection. Its policy allowed subscriptions and retained any applicable $50–$100 consultation fee once review began, including after rejection. Cancellation must precede renewal processing to prevent the next charge; that does not refund an existing order.

Exit timing also needs clarification: the policy’s final-sale clause made prescriptions final after approval AND pharmacy transmission, while the Terms used completed review and/or transmission, subject to policy exceptions. A separate 30-calendar-day purchase cutoff applied even before shipment, except where law required otherwise. We would wait for the applicable terms in writing; our CoreAge review explains the conflicting disclosures.

On November 3, its policy also said that a clinician-advised stop for health concerns leaves eligible remaining prepaid value as store credit rather than cash. It allows transfer to another patient subject to medical approval, or use toward nonprescription products and future eligible services or products.

Kongo: consider one month before a longer payment

Start with the one-month price if you want to try the service. Our Kongo review explains how the three-month plans renew after an introductory offer.

More on Kongo

In November 2026, Kongo advertised regular semaglutide prices of $109 for one month or $285 upfront for three, and tirzepatide at $209 or $387 for those plan lengths. Both pages described limited-time discounts for a new patient’s first three-month order, followed by $285 or $387 every three months, respectively; Kongo can end the offers. Confirm eligibility and the continuing charge. These advertisements do not establish matched prescriptions or supplied quantities.

The one-month option is our starting comparison if you want to assess the service before a longer payment. Kongo’s contact page offered prospective-patient email and member clinical/support chats; telephone service was still marked Coming soon. Written channels may suit a reader who prefers them, but we have not tested response quality or established the clinical visit format.

The FAQ directs cancellation to the portal and pauses to the clinical team. Its Terms make consultations nonrefundable and prescription sales final, while directing filling-error reports through the account. Confirm clinical-rejection and unfulfilled-order exceptions before prepaying; cancellation is not a promise to recover unused money. Our Kongo review separates the plan and exit questions.

These dated disclosures do not establish an equivalent prescription, medication quantity, selected charge or clinical quality. Confirm the product, usable supply, state eligibility, assigned clinician and pharmacy before deciding.

CoreAge Rx
Site position #1

Higher score

KongoFactor scores not reassessed.
Site position #19

Lower score

Score comparison

CoreAge Rx has the higher recorded score — 89.5/100 to 83.8/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

CoreAge Rx scores 89.5/100 (B+).

Before you choose

Before comparing the headline prices, the CoreAge Rx review and the Kongo review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, CoreAge Rx vs Kova and Elara Health and Wellness vs Kongo compare each of them with another graded program, and the list of alternatives to CoreAge Rx ranks the programs closest to CoreAge Rx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueCoreAge Rx +6
92
86
Dose & formulationCoreAge Rx +8
88
80
Clinical oversightCoreAge Rx +9
93
84
Labs & monitoringCoreAge Rx +8
90
82
FulfillmentCoreAge Rx +8
95
87
Contract termsKongo +18
67
85
CoreAge Rx · top barKongo · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricCoreAge RxKongo
WeighScore89.5/10083.8/100
GradeB+B
Site position#1#19
SemaglutideProduct page from $79/mo; navigation $99. Confirm selected quote.$109 one-month plan or $285 every three months advertised; confirm selected charge and supply.
TirzepatideFrom $129/mo advertised; confirm selected charge, supply and renewal.$209 one-month or $387 three-month plan advertised; confirm selected charge and supply.
CoverageUS only; therapy-specific state restrictions applyAll 50 advertised; confirm treatment-specific state availability.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
CoreAge Rx

Site position #1 · B+

Strengths

  • Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
  • Advertises the same price across doses and no membership fee
  • Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy

What to consider

  • Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
  • FAQ no-rebill and payment-timing statements differ from the subscription and order policy
  • FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
  • Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
  • Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
Kongo

Site position #19 · B

Factor scores not reassessed.

Strengths

  • Regular one-month and prepaid totals published
  • Medication, care, supplies and shipping advertised included
  • Portal cancellation and clinical messaging

What to consider

  • Refund and refill cutoffs need confirmation
  • Operator and footer entities need clarification
  • Assigned clinician and pharmacy not established
  • Telephone support marked coming soon

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard